N 6-Methyladenosine Demethylase FTO Controls Macrophage Homeostasis in Diabetic Vasculopathy
Diabetes · 01.01.2025 · 74 (1) · 82-95
DOI: 10.2337/db24-0691 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 24.10.2024. Verfasst von Siguo Feng und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Macrophages. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Diabetic vasculopathy, encompassing complications such as diabetic retinopathy, represents a significant source of morbidity, with inflammation playing a pivotal role in the progression of these complications. This study investigates the influence of N6-methyladenosine demethylase (m6A) modification and the m6A demethylase fat mass and obesity-associated (FTO) protein on macrophage polarization and its subsequent effects on diabetic microvasculopathy. We found that diabetes induces a shift in macrophage polarization toward a proinflammatory M1 phenotype, which is associated with a reduction in m6A modification levels. Notably, FTO emerges as a critical regulator of m6A under diabetic conditions. In vitro experiments reveal that FTO not only modulates macrophage polarization but also mediates their interactions with vascular endothelial cells. In vivo experiments demonstrate that FTO deficiency exacerbates retinal inflammation and microvascular dysfunction in diabetic retinas. Mechanistically, FTO stabilizes mRNA through an m6A-YTHDF2–dependent pathway, thereby activating the PI3K/AKT signaling cascade. Collectively, these findings position FTO as a promising therapeutic target for the management of diabetic vascular complications. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China.
- The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
- Eye Institute and Department of Ophthalmology, Eye and ENT Hospital, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China.
- Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China.
Zitieren
APA
Feng, S., Zhang, Q., Liu, Q., Huang, C., Zhang, H., Wang, F., Zhu, Y., Jian, Q., Chen, X., Jiang, Q., & Yan, B. (2025). N 6-Methyladenosine Demethylase FTO Controls Macrophage Homeostasis in Diabetic Vasculopathy. Diabetes, 74(1), 82-95. https://doi.org/10.2337/db24-0691
Vancouver
Feng S, Zhang Q, Liu Q, Huang C, Zhang H, Wang F, et al. N 6-Methyladenosine Demethylase FTO Controls Macrophage Homeostasis in Diabetic Vasculopathy. Diabetes. 2025;74(1):82-95. doi:10.2337/db24-0691
BibTeX
@article{Feng2025,
author = {Feng, Siguo and Zhang, Qiuyang and Liu, Qing and Huang, Chang and Zhang, Huiying and Wang, Fengsheng and Zhu, Yue and Jian, Qizhi and Chen, Xue and Jiang, Qin and Yan, Biao},
title = {N 6-Methyladenosine Demethylase FTO Controls Macrophage Homeostasis in Diabetic Vasculopathy},
journal = {Diabetes},
year = {2025},
volume = {74},
number = {1},
pages = {82--95},
doi = {10.2337/db24-0691}
}
EUVIMED